Acetazolamide for the Prevention of High Altitude Illness: a Comparison of Dosing

Completed · Phase 4

Conditions studied: Prophylaxis of Acute Mountain Sickness

In brief

This is a phase 4, randomized, double-blinded interventional trial comparing alternative doses of Acetazolamide for the prevention of High Altitude Illness.

Key facts

Study ID

NCT01993667

Run by

University of Utah

People needed

130

Starts

2012-03-01

Expected to finish

2016-11-01

Last updated by the study team

2019-01-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• 18 years or older
• English or Indian speaking
• Mountaineers or trekkers who plan to climb Mt. McKinley or trek to Base Camp on Mt. Everest

You may not qualify if…

• Low sodium and/potassium blood serum levels
• Kidney disease or dysfunction
• Liver disease, dysfunction, or cirrhosis
• Suprarenal gland failure or dysfunction
• Hyperchloremic acidosis
• Angle-closure glaucoma
• Taking high dose aspirin (over 325 mg/day)
• Any reaction to sulfa drugs or acetazolamide
• Pregnant or lactating women

Where it is running

• University of Utah Health Sciences Center — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.